Literature DB >> 21834568

Total synthesis of (+)-SCH 351448.

Kaicheng Zhu1, James S Panek.   

Abstract

A convergent synthesis of (+)-SCH 351448 (1), a monosodium salt of a C(2)-symmetric macrodiolide, is described. Our approach is based on a [4 + 2] annulation with a chiral allyl silane (anti-5c) to assemble the pyran subunits. Homodimerization was carried out in a stepwise fashion; initial esterification at C29' followed by macrocyclization at C29 afforded the desired macrodiolide.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834568      PMCID: PMC3164292          DOI: 10.1021/ol201863b

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  17 in total

1.  Total synthesis of (-)-apicularen A.

Authors:  Qibin Su; James S Panek
Journal:  J Am Chem Soc       Date:  2004-03-03       Impact factor: 15.419

2.  A concise synthesis of (+)-SCH 351448.

Authors:  Omid Soltani; Jef K De Brabander
Journal:  Org Lett       Date:  2005-06-23       Impact factor: 6.005

3.  Enantioselective total synthesis of (+)-SCH 351448.

Authors:  Michael T Crimmins; Grace S Vanier
Journal:  Org Lett       Date:  2006-06-22       Impact factor: 6.005

4.  Formal synthesis of (+)-SCH 351448: the Prins cyclization approach.

Authors:  Kok-Ping Chan; Yvonne Hui Ling; Teck-Peng Loh
Journal:  Chem Commun (Camb)       Date:  2007-01-24       Impact factor: 6.222

5.  Assignment of absolute configuration to SCH 351448 via total synthesis.

Authors:  Lael L Cheung; Shinji Marumoto; Christopher D Anderson; Scott D Rychnovsky
Journal:  Org Lett       Date:  2008-06-11       Impact factor: 6.005

6.  A formal synthesis of SCH 351448.

Authors:  Heekwang Park; Hyoungsu Kim; Jiyong Hong
Journal:  Org Lett       Date:  2011-06-21       Impact factor: 6.005

Review 7.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 8.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

9.  Enantioselective total synthesis of +-jasplakinolide.

Authors:  Arun K Ghosh; Deuk Kyu Moon
Journal:  Org Lett       Date:  2007-05-08       Impact factor: 6.005

10.  Total synthesis of (+)-SCH 351448.

Authors:  Eun Joo Kang; Eun Jin Cho; Young Eun Lee; Mi Kyung Ji; Dong Mok Shin; Young Keun Chung; Eun Lee
Journal:  J Am Chem Soc       Date:  2004-03-10       Impact factor: 15.419

View more
  6 in total

1.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

2.  Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin Analogues.

Authors:  Paul A Wender; Kelvin L Billingsley
Journal:  Synthesis (Stuttg)       Date:  2013       Impact factor: 3.157

3.  Achmatowicz Reaction and its Application in the Syntheses of Bioactive Molecules.

Authors:  Arun K Ghosh; Margherita Brindisi
Journal:  RSC Adv       Date:  2016-11-24       Impact factor: 3.361

4.  Formal Synthesis of Premisakinolide A and C(19)-C(32) of Swinholide A via Site-Selective C-H Allylation and Crotylation of Unprotected Diols.

Authors:  Inji Shin; Michael J Krische
Journal:  Org Lett       Date:  2015-10-02       Impact factor: 6.005

5.  Total Synthesis of (+)-SCH 351448: Efficiency via Chemoselectivity and Redox-Economy Powered by Metal Catalysis.

Authors:  Gang Wang; Michael J Krische
Journal:  J Am Chem Soc       Date:  2016-06-23       Impact factor: 15.419

6.  Mechanistic and computational studies of exocyclic stereocontrol in the synthesis of bryostatin-like cis-2,6-disubstituted 4-alkylidenetetrahydropyrans by Prins cyclization.

Authors:  Yasuyuki Ogawa; Phillip P Painter; Dean J Tantillo; Paul A Wender
Journal:  J Org Chem       Date:  2012-11-07       Impact factor: 4.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.